PlainRecalls
FDA Drug Moderate Class II Terminated

Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6

Reported: February 28, 2024 Initiated: February 13, 2024 #D-0327-2024

Product Description

Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6

Reason for Recall

Failed Impurities/Degradation Specifications: Out-of-specification test results.

Details

Units Affected
46,037 Bottles
Distribution
Nationwide in the USA
Location
Brookhaven, NY

Frequently Asked Questions

What product was recalled?
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6. Recalled by Amneal Pharmaceuticals of New York, LLC. Units affected: 46,037 Bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out-of-specification test results.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 28, 2024. Severity: Moderate. Recall number: D-0327-2024.